[1] L. C. Zhao, T. B. Lautz, J. J. Meeks, and M. Maizels, “Pediatric
testicular torsion epidemiology using a national database: incidence, risk of orchiectomy and possible measures toward
improving the quality of care,” Journal of Urology, vol. 186,
no. 5, pp. 2009–2013, 2011.
[2] J. M. Mansbach, P. Forbes, and C. Peters, “Article,” Archives of
Pediatrics & Adolescent Medicine, vol. 159, no. 12, pp. 1167–
1171, 2005.
[3] L. B. Mellick, J. E. Sinex, R. W. Gibson, and K. Mears, “A systematic review of testicle survival time after a torsion event,”
Pediatric Emergency Care, vol. 35, no. 12, pp. 821–825, 2019.
[4] A. J. Visser and C. F. Heyns, “Testicular function after torsion
of the spermatic cord,” BJU International, vol. 92, no. 3,
pp. 200–203, 2003.
[5] X. Zhang, J. Zhang, Z. Cai, X. Wang, W. Lu, and H. Li, “Effect
of unilateral testicular torsion at different ages on male fertility,” Journal of International Medical Research, vol. 48, no. 4,
p. 300060520918792, 2020.
[6] L. B. Becker, “New concepts in reactive oxygen species and cardiovascular reperfusion physiology,” Cardiovascular Research,
vol. 61, no. 3, pp. 461–470, 2004.
[7] A. Kato, C. Gabay, T. Okaya, and A. B. Lentsch, “Specific role
of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion,” American Journal of Pathology, vol. 161,
no. 5, pp. 1797–1803, 2002.
[8] N. Maekawa, H. Wada, T. Kanda et al., “Improved myocardial
ischemia/reperfusion injury in mice lacking tumor necrosis
factor-α,” Journal of the American College of Cardiology,
vol. 39, no. 7, pp. 1229–1235, 2002.
[9] M. D. Menger, M. Rücker, and B. Vollmar, “Capillary dysfunction in striated muscle ischemia/reperfusion,” Shock, vol. 8,
no. 1, pp. 2–7, 1997.
[10] T. L. Vanden Hoek, Z. Shao, C. Li, R. Zak, P. T. Schumacker,
and L. B. Becker, “Reperfusion injury on cardiac myocytes
after simulated ischemia,” American Journal of PhysiologyHeart and Circulatory Physiology, vol. 270, no. 4, pp. H1334–
H1341, 1996.
[11] M. J. Anderson, J. K. Dunn, L. I. Lipshultz, and M. Coburn,
“Semen quality and endocrine parameters after acute testicular
torsion,” Journal of Urology, vol. 147, no. 6, pp. 1545–1550,
1992.
[12] W. E. Thomas, M. J. Cooper, G. A. Crane, G. Lee, and R. C.
Williamson, “Testicular exocrine malfunction after torsion,”
The Lancet, vol. 2, no. 8416, pp. 1357–1360, 1984.
[13] B. Erol, M. Bozlu, V. Hanci, H. Tokgoz, S. Bektas, and
G. Mungan, “Coenzyme Q10 treatment reduces lipid peroxidation, inducible and endothelial nitric oxide synthases, and
germ cell-specific apoptosis in a rat model of testicular ischemia/reperfusion injury,” Fertility & Sterility, vol. 93, no. 1,
pp. 280–282, 2010.
[14] R. Bilommi, B. A. Nawas, D. D. Kusmayadi, R. Diposarosa,
A. Chairul, and B. S. Hernowo, “The effects of glutathione on
malondialdehyde expression and seminiferous tubule damage
in experimental testicular torsion–detorsion in Wistar rats,”
Journal of Pediatric Urology, vol. 9, no. 6, Part B, pp. 1059–
1063, 2013.
[15] M. Kanter, “Protective effects of melatonin on testicular torsion/detorsion-induced ischemia–reperfusion injury in rats,”
Experimental & Molecular Pathology, vol. 89, no. 3, pp. 314–
320, 2010.
[16] E. Yuluğ, S. Türedi, E. Karagüzel, Ö. Kutlu, A. Menteşe, and
A. Alver, “The short term effects of resveratrol on ischemiareperfusion injury in rat testis,” Journal of Pediatric Surgery,
vol. 49, no. 3, pp. 484–489, 2014.
[17] M. Bašković, A. K. Bojanac, N. Sinčić, M. H. Perić, D. Krsnik,
and D. Ježek, “The effect of astaxanthin on testicular torsiondetorsion injury in rats - detailed morphometric evaluation
of histological sections,” Journal of Pediatric Urology, vol. 17,
no. 4, pp. 439.e1–439.e12, 2021.
[18] D. Dokmeci, M. Kanter, M. Inan et al., “Protective effects of
ibuprofen on testicular torsion/detorsion-induced ischemia/
reperfusion injury in rats,” Archives of Toxicology, vol. 81,
no. 9, pp. 655–663, 2007.
[19] D. Sarıbal, E. Erdem, N. E. Güngör-Ordueri, A. Usta,
C. Karakuş, and M. Karacan, “Metformin decreases testicular
damages following ischaemia/reperfusion injury in rats,”
Andrologia, vol. 52, no. 2, article e13481, 2020.
[20] J. G. Mogilner, M. Lurie, A. G. Coran, O. Nativ, E. Shiloni, and
I. Sukhotnik, “Effect of diclofenac on germ cell apoptosis fol-
Andrologia
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
lowing testicular ischemia-reperfusion injury in a rat,” Pediatric Surgery International, vol. 22, no. 1, pp. 99–105, 2006.
A. Beheshtian, A. H. Salmasi, S. Payabvash et al., “Protective
effects of sildenafil administration on testicular torsion/detorsion damage in rats,” World Journal of Urology, vol. 26,
no. 2, pp. 197–202, 2008.
P. Dejban, N. Rahimi, N. Takzare, M. Jahansouz, and A. R.
Dehpour, “Protective effects of sumatriptan on ischaemia/
reperfusion injury following torsion/detorsion in ipsilateral
and contralateral testes of rat,” Andrologia, vol. 51, no. 9, article e13358, 2019.
K. Sumii, H. Miyake, N. Enatsu, K. Chiba, and M. Fujisawa,
“Characterization of urocortin as an anti-apoptotic protein in
experimental ischemia-reperfusion model of the rat testis,”
Biochemical & Biophysical Research Communications,
vol. 479, no. 2, pp. 387–392, 2016.
A. Kobayashi, M. I. Kang, H. Okawa et al., “Oxidative stress
sensor Keap1 functions as an adaptor for Cul3-based E3 ligase
to regulate proteasomal degradation of Nrf2,” Molecular &
Cellular Biology, vol. 24, no. 16, pp. 7130–7139, 2004.
A. Kobayashi, M. I. Kang, Y. Watai et al., “Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1,” Molecular & Cellular Biology,
vol. 26, no. 1, pp. 221–229, 2006.
T. Iso, T. Suzuki, L. Baird, and M. Yamamoto, “Absolute
amounts and status of the Nrf2-Keap1-Cul3 complex within
cells,” Molecular & Cellular Biology, vol. 36, no. 24,
pp. 3100–3112, 2016.
K. Itoh, T. Chiba, S. Takahashi et al., “An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying
enzyme genes through antioxidant response elements,” Biochemical & Biophysical Research Communications, vol. 236,
no. 2, pp. 313–322, 1997.
B. N. Chorley, M. R. Campbell, X. Wang et al., “Identification
of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha,” Nucleic Acids Research, vol. 40, no. 15,
pp. 7416–7429, 2012.
Y. Hirotsu, F. Katsuoka, R. Funayama et al., “Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic
networks,” Nucleic Acids Research, vol. 40, no. 20, pp. 10228–
10239, 2012.
M. D. Maines, “The heme oxygenase system: a regulator of second messenger gases,” Annual Review of Pharmacology & Toxicology, vol. 37, no. 1, pp. 517–554, 1997.
S. F. Llesuy and M. L. Tomaro, “Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage,” Biochimica et
Biophysica Acta (BBA) - Molecular Cell Research, vol. 1223,
no. 1, pp. 9–14, 1994.
D. Siegel, D. L. Gustafson, D. L. Dehn et al., “NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger,” Molecular Pharmacology, vol. 65, no. 5, pp. 1238–1247, 2004.
S. E. Nennig and J. R. Schank, “The role of NFkB in drug
addiction: beyond inflammation,” Alcohol & Alcoholism,
vol. 52, no. 2, pp. 172–179, 2017.
P. A. Baeuerle and D. Baltimore, “IκB: a specific inhibitor of
the NF-κB transcription factor,” Science, vol. 242, no. 4878,
pp. 540–546, 1988.
G. Ghosh, G. van Duyne, S. Ghosh, and P. B. Sigler, “Structure
of NF-κB p50 homodimer bound to a κB site,” Nature,
vol. 373, no. 6512, pp. 303–310, 1995.
Andrologia
[36] M. D. Jacobs and S. C. Harrison, “Structure of an IκBα/NF-κB
complex,” Cell, vol. 95, no. 6, pp. 749–758, 1998.
[37] H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999.
[38] M. Karin, “How NF-κB is activated: the role of the IκB kinase
(IKK) complex,” Oncogene, vol. 18, no. 49, pp. 6867–6874, 1999.
[39] R. K. Thimmulappa, H. Lee, T. Rangasamy et al., “Nrf2 is a
critical regulator of the innate immune response and survival
during experimental sepsis,” Journal of Clinical Investigation,
vol. 116, no. 4, pp. 984–995, 2006.
[40] L. G. Chen, Y. Q. Zhang, Z. Z. Wu, C. W. Hsieh, C. S. Chu, and
B. S. Wung, “Peanut arachidin-1 enhances Nrf2-mediated protective mechanisms against TNF-α-induced ICAM-1 expression and NF-ΚB activation in endothelial cells,” International
Journal of Molecular Medicine, vol. 41, no. 1, pp. 541–547, 2018.
[41] X. Qi, Z. Qin, J. Tang et al., “Omega-3 polyunsaturated fatty
acids ameliorates testicular ischemia- reperfusion injury
through the induction of Nrf2 and inhibition of NF-κB in
rats,” Experimental & Molecular Pathology, vol. 103, no. 1,
pp. 44–50, 2017.
[42] Y. Zhang, Y. Cao, F. Wang et al., “4-Nitrophenol induces activation of Nrf2 antioxidant pathway and apoptosis of the germ
cells in rat testes,” Environmental Science & Pollution Research
International, vol. 23, no. 13, pp. 13035–13046, 2016.
[43] Y. Wang, T. T. Zhao, H. Y. Zhao, and H. Wang, “Melatonin
protects methotrexate-induced testicular injury in rats,” European Review for Medical & Pharmacological Sciences, vol. 22,
no. 21, pp. 7517–7525, 2018.
[44] R. J. Fox, D. H. Miller, J. T. Phillips et al., “Placebo-controlled
phase 3 study of Oral BG-12 or glatiramer in multiple sclerosis,” New England Journal of Medicine, vol. 367, no. 12,
pp. 1087–1097, 2012.
[45] R. Gold, L. Kappos, D. L. Arnold et al., “Placebo-controlled
phase 3 study of oral BG-12 for relapsing multiple sclerosis,”
New England Journal of Medicine, vol. 367, no. 12, pp. 1098–
1107, 2012.
[46] R. Gold, D. L. Arnold, A. Bar-Or et al., “Long-term effects of
delayed-release dimethyl fumarate in multiple sclerosis:
interim analysis of ENDORSE, a randomized extension study,”
Multiple Sclerosis, vol. 23, no. 2, pp. 253–265, 2017.
[47] R. A. Linker and A. Haghikia, “Dimethyl fumarate in multiple
sclerosis: latest developments, evidence and place in therapy,”
Therapeutic Advances in Chronic Disease, vol. 7, no. 4,
pp. 198–207, 2016.
[48] R. H. Scannevin, S. Chollate, M. Y. Jung et al., “Fumarates promote cytoprotection of central nervous system cells against
oxidative stress via the nuclear factor (erythroid-derived 2)like 2 pathway,” Journal of Pharmacology & Experimental
Therapeutics, vol. 341, no. 1, pp. 274–284, 2012.
[49] K. Ghoreschi, J. Brück, C. Kellerer et al., “Fumarates improve
psoriasis and multiple sclerosis by inducing type II dendritic
cells,” Journal of Experimental Medicine, vol. 208, no. 11,
pp. 2291–2303, 2011.
[50] X. Zhen, L. Jindong, Z. Yang et al., “Activation of Nrf2 pathway by dimethyl fumarate attenuates renal ischemia- reperfusion injury,” Transplantation Proceedings, vol. 53, no. 7,
pp. 2133–2139, 2021.
[51] C. Takasu, N. D. Vaziri, S. Li et al., “Treatment with dimethyl
fumarate ameliorates liver ischemia/reperfusion injury,”
World Journal of Gastroenterology, vol. 23, no. 25, pp. 4508–
4516, 2017.
[52] S. G. Johnsen, “Testicular biopsy score count–a method for
registration of spermatogenesis in human testes: normal values
and results in 335 hypogonadal males,” Hormones, vol. 1,
no. 1, pp. 2–25, 1970.
[53] M. J. Cosentino, M. Nishida, R. Rabinowitz, and A. T. Cockett,
“Histopathology of prepubertal rat testes subjected to various
durations of spermatic cord torsion,” Journal of Andrology,
vol. 7, no. 1, pp. 23–31, 1986.
[54] Y. Kanda, “Investigation of the freely available easy-to-use
software ‘EZR’ for medical statistics,” Bone Marrow Transplantation, vol. 48, no. 3, pp. 452–458, 2013.
[55] G. Barroso, M. Morshedi, and S. Oehninger, “Analysis of DNA
fragmentation, plasma membrane translocation of phosphatidylserine and oxidative stress in human spermatozoa,” Human
Reproduction, vol. 15, no. 6, pp. 1338–1344, 2000.
[56] D. Santi, G. Spaggiari, and M. Simoni, “Sperm DNA fragmentation index as a promising predictive tool for male infertility
diagnosis and treatment management - meta-analyses,” Reproductive Biomedicine Online, vol. 37, no. 3, pp. 315–326, 2018.
[57] M. P. Hedger and A. Meinhardt, “Cytokines and the immunetesticular axis,” Journal of Reproductive Immunology, vol. 58,
no. 1, pp. 1–26, 2003.
[58] K. L. Loveland, B. Klein, D. Pueschl et al., “Cytokines in male
fertility and reproductive pathologies: immunoregulation and
beyond,” Frontiers in Endocrinology, vol. 8, p. 307, 2017.
[59] S. Shimizu, P. Tsounapi, F. Dimitriadis, Y. Higashi, T. Shimizu,
and M. Saito, “Testicular torsion–detorsion and potential therapeutic treatments: a possible role for ischemic postconditioning,” International Journal of Urology, vol. 23, no. 6, pp. 454–
463, 2016.
[60] G. Vaos and N. Zavras, “Antioxidants in experimental
ischemia-reperfusion injury of the testis: where are we heading
towards?,” World Journal of Methodology, vol. 7, no. 2, pp. 37–
45, 2017.
[61] G. Yu, Y. Guan, L. Liu et al., “The protective effect of lowenergy shock wave on testicular ischemia- reperfusion injury
is mediated by the PI3K/AKT/NRF2 pathway,” Life Sciences,
vol. 213, pp. 142–148, 2018.
[62] Z. Qin, K. Zhu, J. Xue et al., “Zinc-induced protective effect for
testicular ischemia-reperfusion injury by promoting antioxidation via microRNA-101-3p/Nrf2 pathway,” Aging, vol. 11,
no. 21, pp. 9295–9309, 2019.
[63] Á. Cores, M. Piquero, M. Villacampa, R. León, and J. C.
Menéndez, “NRF2 regulation processes as a source of potential
drug targets against neurodegenerative diseases,” Biomolecules, vol. 10, no. 6, p. 904, 2020.
[64] Y. Yao, W. Miao, Z. Liu et al., “Dimethyl fumarate and monomethyl fumarate promote post-ischemic recovery in mice,”
Translational Stroke Research, vol. 7, no. 6, pp. 535–547, 2016.
[65] L. He, P. Li, L. H. Yu et al., “Protective effects of proanthocyanidins against cadmium-induced testicular injury through the
modification of Nrf2-Keap1 signal path in rats,” Environmental Toxicology and Pharmacology, vol. 57, pp. 1–8, 2018.
[66] A. T. Fahim, A. A. A. El-Fattah, N. A. H. Sadik, and B. M. Ali,
“Resveratrol and dimethyl fumarate ameliorate testicular dysfunction caused by chronic unpredictable mild stress-induced
depression in rats,” Archives of Biochemistry & Biophysics,
vol. 665, pp. 152–165, 2019.
...
論文の公開元へ
